Irene Lang

Interventional cardiologist / Cardiologist
Medizinische Universität Wien - Wien, Austria

Latest contributions

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

22 May 2025 – From EuroPCR 2025

Deep dive into pulmonary embolism catheter technologies through case-based presentations. Learn about established and novel devices for acute pulmonary embolism treatment, indications for device use, and management of procedural complications to optimize patient outcomes.

Deep dive on pulmonary embolism catheter technologies - Clinical trial data and how to use

How are we going to treat these sick patients presenting with pulmonary embolism?

21 May 2025 – From EuroPCR 2025

Address the urgent clinical question of how to treat patients presenting with pulmonary embolism across varying risk profiles. This session covers risk stratification and discusses interventional treatment options through detailed case analyses of intermediate and high-risk patients, providing practical guidance for individualized management.

How are we going to treat these sick patients presenting with pulmonary embolism?

Best companion's cases on imaging for calcified lesions

20 May 2025 – From EuroPCR 2025

Join this session to explore cutting-edge imaging-guided strategies for treating calcified coronary lesions. Featuring OCT guidance, CT density analysis, and innovative zero-contrast PCI approaches including lithotripsy, this session highlights novel and ultra-low contrast interventions tailored for complex calcified cases and kidney failure patients.

Best companion's cases on imaging for calcified lesions

Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism

16 May 2024 – From EuroPCR 2024

In this EuroPCR 2024 session, study the case of a patient with high-risk pulmonary embolism and another with intermediate to high-risk pulmonary embolism, delve into discussions on clinical evidence for mechanical thrombectomy in pulmonary embolism, acquire skills to evaluate eligibility for mechanical thrombectomy, and learn how to...

Why mechanical thrombectomy should be considered in the management of acute pulmonary embolism

Revisiting thrombus aspiration in STEMI with continuous power aspiration system

15 May 2024 – From EuroPCR 2024

Tune into this 2024 session for insights into the latest ESC guidelines, strategies to prevent and treat no reflow, and an examination of trials like TASTE, TAPAS, and TOTAL on coronary thrombus management. Explore also the outcomes of the CHEETAH study, pondering a potential paradigm shift,...

Revisiting thrombus aspiration in STEMI with continuous power aspiration system

Devices in pulmonary embolism - Why you should be interested!

15 May 2024 – From EuroPCR 2024

This session provides a comprehensive overview of device-based pulmonary embolism treatment. Experts will discuss the clinical problem of pulmonary embolism, the importance of forming a dedicated team, and the available devices and their characteristics. The session will also feature case-based discussions on the use of catheter-directed...

Devices in pulmonary embolism - Why you should be interested!

Current trends in the invasive treatment of pulmonary embolism

18 May 2023 – From EuroPCR 2023

Embark on an exploration of the current trends in the invasive treatment of pulmonary embolism. Grasp the intricacies of establishing a catheter intervention service, navigate patient selection for advanced devices like catheter-directed thrombolysis and mechanical thrombectomy, and stay ahead by reviewing the latest clinical trials in...

Current trends in the invasive treatment of pulmonary embolism

Tricuspid valve disease: state-of-the-art

23 Nov 2021 – From PCR London Valves 2021

Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...

Tricuspid valve disease: state-of-the-art